Form 4 Filing for MoonLake Immunotherapeutics (MLTX)

This filing details a Form 4 report for MoonLake Immunotherapeutics (MLTX), concerning stock transactions by reporting owner Xavier Ramnik, who is a director at the company. On June 17, 2026, Ramnik was granted an option to buy 22,195 Class A ordinary shares at a price of $0.00 per share. This option is set to vest in full on either June 17, 2027, or the date of the company's next annual general meeting, contingent upon Ramnik's continued service. The underlying shares are Class A ordinary shares with a par value of $0.0001 per share. Following this transaction, Ramnik holds 22,195 shares. The option has an expiration date of June 17, 2036, and a conversion or exercise price of $19.19.